Details for New Drug Application (NDA): 020697
✉ Email this page to a colleague
The generic ingredient in TASMAR is tolcapone. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the tolcapone profile page.
Pharmacology for NDA: 020697
Mechanism of Action | Catechol O-Methyltransferase Inhibitors |
Suppliers and Packaging for NDA: 020697
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TASMAR | tolcapone | TABLET;ORAL | 020697 | NDA | Bausch Health US LLC | 0187-0938 | 0187-0938-01 | 90 TABLET, FILM COATED in 1 BOTTLE (0187-0938-01) |
TASMAR | tolcapone | TABLET;ORAL | 020697 | NDA AUTHORIZED GENERIC | Oceanside Pharmaceuticals | 68682-938 | 68682-938-90 | 90 TABLET, FILM COATED in 1 BOTTLE (68682-938-90) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Jan 29, 1998 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Jan 29, 1998 | TE: | RLD: | No |
Expired US Patents for NDA 020697
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | TASMAR | tolcapone | TABLET;ORAL | 020697-001 | Jan 29, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | TASMAR | tolcapone | TABLET;ORAL | 020697-002 | Jan 29, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | TASMAR | tolcapone | TABLET;ORAL | 020697-002 | Jan 29, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription